insomnia
Medications
SN instructed patient about the Restoril ( temazepam ) is a benzodiazepine. Temazepam affects chemicals in the brain that may be unbalanced in people with sleep problems ( insomnia ). Restoril is used to treat insomnia symptoms, such as trouble falling asleep or staying asleep. Restoril works by slowing down the central nervous system ( brain ), causing drowsiness which helps patients fall asleep.
SN instructed patient about the Ambein is a benzodiazepine. Zolpidem affects chemicals in the brain that may be unbalanced in people with sleep problems ( insomnia ). Ambein is used to treat insomnia symptoms, such as trouble falling asleep or staying asleep. Ambien works by slowing down the central nervous system ( brain ), causing drowsiness which helps patients fall asleep.
Instructed in new medication Pulmicort to manage asthma. In addition, warned of possible S/E such as headache, pain, insomnia, asthenia, rhinitis, voice alteration, sinusitis, pharyngitis, dry mouth, nausea, vomiting, abdominal pain, taste perversion, cought, etc.
Instructed in new medication Sulfaprim and in S/E such as headache, mental depression, aseptic meningitis, tinnitus, apathy, seizures, hallucinations, ataxia, nervousness, fatigue, vertigo, insomnia, thrombophlebitis, nausea, vomiting, diarrhea, abdominal pain, anorexia, stomatitis, pancreatitis, pseudomembranous colitis, toxic nephrosis with oliguria and anuria, crystalluria, hematuria, interstitial nephritis, agranulocytosis, aplastic anemia, megaloblastic anemia, thrombocytopenia, leukopenia, hemolytic anemia, jaundice, hepatic necrosis, arthralgia, myalgia, muscle weakness, pulmonary infiltrates, erythema multiforme, Stevens-Johnson syndrome, generalized skin eruption, toxic epidermal necrolysis, exfoliative dermatitis, photosensitivity, urticaria, pruritus, hypersensitivity reactions, serum sickness, drug fever and anaphylaxis.
Instructed in new medication Cozaar and in S/E such as dizziness, asthenia, fatigue, headache, insomnia, edema, chest pain, nasal congestion, sinusitis, pharyngitis, sinus disorder, abdominal pain, nausea, diarrhea, dyspepsia, muscle cramps, myalgia, back or leg pain, cough, upper respiratory infection, angioedema, asthenia, fatigue, fever, hypesthesia, chest pain, hypotension, orthostatic hypotension, sinusitis, cataract, diarrhea, dyspepsia, gastritis, urinary tract infection, anemia, hyperkalemia, hypoglycemia, weight gain, back pain, leg or knee pain, muscle weakness, cough, bronchitis, cellulites and others.
Instructed in new medication Sinemet and in S/E such as choreiform, dystonic, dyskinetic movements, involuntary grimacing, head movements, myoclonic body jerks, ataxia, tremor, muscle twitching, bradykinetic episodes, psychiatric disturbances, anxiety, disturbing dreams, euphoria, malaise, fatigue, severe depression, suicidal tendencies, dementia, delirium, hallucinations (may necessitate reduction or withdrawal of drug), confusion, insomnia, agitation, orthostatic hypotension, cardiac irregularities, phlebitis, blepharospasm, blurred vision, diplopia, mydriasis or miosis, oculogyric crises, excessive salivation, dry mouth, bitter taste, nausea, vomiting, anorexia, constipation, flatulence, diarrhea, abdominal pain, urinary frequency, urine retention, urinary incontinence, darkened urine, priapism, hemolytic anemia, thrombocytopenia, leukopenia, agranulocytosis, hepatotoxicity, weight loss (may occur at start of therapy), hiccups, hyperventilation, and dark perspiration.
Instructed in new medication Prednisone and in S/E such as euphoria, insomnia, psychotic behavior, vertigo, headache, paresthesia, seizures, pseudotumor cerebri, heart failure, hypertension, edema, arrhythmias, thrombophlebitis, thromboembolism, cataracts, glaucoma, peptic ulceration, GI irritation, increased appetite, pancreatitis, nausea, vomiting, menstrual irregularities, increased urine calcium levels, hypokalemia, hyperglycemia, carbohydrate intolerance, growth suppression in children, muscle weakness, osteoporosis, hirsutism, delayed wound healing, acne and various skin eruptions.
Instructed in new medication Protonix to manage esophagitis. In addition, warned of possible S/E such as headache, insomnia, asthenia, dizziness, chest pain, pharyngitis, rhinitis, sinusitis, diarrhea, flatulence, abdominal pain, eructation, constipation, nausea, vomiting, urinary frequency, hyperglycemia, back pain, neck pain, hypertonia, rash, bronchitis, increased cough, etc. The drug can be taken without regard to meal.
Instructed in new medication Wellbutrin to manage depression. In addition, warned of possible S/E such as headache, seizures, anxiety, confusion, delusions, euphoria, hostility, impaired sleep quality, insomnia, sedation, tremor, akinesia, akathisia, agitation, dizziness, fatigue, syncope, fever, arrhythmias, hypertension, hypotension, palpitations, tachycardia, auditory disturbances, blurred vision, dry mouth, taste disturbance, increased appetite, constipation, dyspepsia, nausea, vomiting, anorexia, diarrhea, impotence, menstrual complaints, urinary frequency, urine retention, weight loss, weight gain, arthritis, pruritus, rash, cutaneous temperature disturbance, excessive diaphoresis, chills and decreased libido. Advised to avoid prolonged sun exposure and to use sun block.
Instructed in new medication Alprazolam to manage anxiety. In addition, warned of possible S/E such as drowsiness, light-headedness, headache, confusion, tremor, dizziness, syncope, depression, insomnia, memory impairment, nervousness, minor changes in EEG patterns, hypotension, tachycardia, blurred vision, nasal congestion, dry mouth, nausea, vomiting, diarrhea, constipation, increased salivation, weight gain or loss, muscle rigidity, dermatitis. Avoid hazardous activities that require alertness and good psychomotor coordination until CNS effects of drug are known. Avoid alcohol while taking drug. Smoking may decrease effectiveness of drug. Do not stop using drug abruptly because withdrawal symptoms or seizures may occur.